Increased glomerular filtration rate in patients with major burns and its effect on the pharmacokinetics of tobramycin.
about
Fluconazole pharmacokinetics in burn patientsAntibiotic dosing in the 'at risk' critically ill patient: Linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients.Pharmacokinetics of cefepime in patients with thermal burn injury.Estimation of renal function in the intensive care unit: the covert concepts brought to lightDecreasing the time to achieve therapeutic vancomycin concentrations in critically ill patients: developing and testing of a dosing nomogramVancomycin pharmacokinetics in burn patients and intravenous drug abusersIncreased creatinine clearance in polytrauma patients with normal serum creatinine: a retrospective observational study.Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients.A population pharmacokinetic approach to ceftazidime use in burn patients: influence of glomerular filtration, gender and mechanical ventilationAssessment of renal function in clinical practice at the bedside of burn patients.Aztreonam pharmacokinetics in burn patientsAutologous creatinine clearance in a case of necrotizing fasciitis and anuria.Vasopressin: a novel target for the prevention and retardation of kidney disease?A Systematic Review of Vancomycin Dosing and Monitoring in Burn Patients.Gap analysis of pharmacokinetics and pharmacodynamics in burn patients: a review.Survival and therapy of burn patients at the threshold of the twenty-first century: a review.Determination of tobramycin pharmacokinetics in burn patients to evaluate the potential utility of once-daily dosing in this population.Reappraisal of guidelines for pharmacokinetic monitoring of aminoglycosides.Optimization and evaluation of piperacillin plus tobramycin combination dosage regimens against Pseudomonas aeruginosa for patients with altered pharmacokinetics via the hollow-fiber infection model and mechanism-based modeling.
P2860
Q33692868-9FD646B9-5713-46DB-9FDC-5228BA5F8E13Q33824276-788C2CAB-268C-4450-B863-D598F5FCD40CQ33978205-47B2D269-1172-4A5A-9B8D-5F9507EE3A7DQ34711649-1E46EE8D-F5B5-4B1A-9FD2-251C08461D8CQ34777837-E0376DD9-17A1-449B-A3AB-71046276EC5EQ35253581-4FE99BD9-8672-4C15-910A-706C819018F7Q35566960-9245037B-4EBE-4749-8E8A-C5946D15C128Q35668521-D697F059-BD17-4999-AAC5-A615A0FCC8EFQ36024489-EE2CA6AA-92B3-4AC4-9FD4-89EB13DA74D3Q36025095-FF172658-8C55-4DA7-9C57-9BB1D0B4D467Q36752546-40005B6D-EDBB-4D91-99A5-0F5B8F992C95Q37011282-F40CDFEB-AAA8-4232-AC35-F2E18656E9B6Q38084471-5B4046EC-2A5E-49CB-97A9-D26C1E1D3EBBQ38271273-CA75A741-47F7-474B-AE5A-86232E4580E4Q38459977-6E7508B8-8983-4C7F-8CCB-6EA9ECC4C6A4Q41006933-B102E115-9867-482A-AC68-7B16FAEBD136Q42247460-39EACE9D-30E8-488D-B4F0-2BBF202E65C0Q45006893-B9A76827-DBA1-4F87-B119-9DBA502A1476Q49792113-049AEC41-8F7E-4DC0-B183-94E6BE43A287
P2860
Increased glomerular filtration rate in patients with major burns and its effect on the pharmacokinetics of tobramycin.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh-hant
name
Increased glomerular filtratio ...... harmacokinetics of tobramycin.
@en
Increased glomerular filtratio ...... harmacokinetics of tobramycin.
@nl
type
label
Increased glomerular filtratio ...... harmacokinetics of tobramycin.
@en
Increased glomerular filtratio ...... harmacokinetics of tobramycin.
@nl
prefLabel
Increased glomerular filtratio ...... harmacokinetics of tobramycin.
@en
Increased glomerular filtratio ...... harmacokinetics of tobramycin.
@nl
P2093
P1476
Increased glomerular filtratio ...... harmacokinetics of tobramycin.
@en
P2093
P304
P356
10.1056/NEJM197810262991703
P407
P577
1978-10-01T00:00:00Z